DAOVEGAN Trademark

Trademark Overview

On Wednesday, December 6, 2023, a trademark application was filed for DAOVEGAN with the United States Patent and Trademark Office. The USPTO has given the DAOVEGAN trademark a serial number of 98302138. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, September 19, 2024. This trademark is owned by STADA Arzneimittel AG. The DAOVEGAN trademark is filed in the Pharmaceutical Products category with the following description:

Vegan pharmaceutical preparations for the treatment of Histamine Intolerance containing diamine oxidase enzymes; Vegan chemico-pharmaceutical pharmaceutical preparations for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; Vegan sanitary preparations for medical purposes featuring diamine oxidase enzymes; Vegan biological preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; Vegan chemical preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; Vegan diamine oxidase enzymes and diamine oxidase enzyme preparations for medical purposes; dietetic foods adapted for medical purposes containing diamine oxidase enzymes; diagnostic preparations for medical purposes containing diamine oxidase enzymes; Vegan chemical reagents for medical purposes containing diamine oxidase enzymes; Vegan nutritional additives for medical purposes for u...
daovegan

General Information

Serial Number98302138
Word MarkDAOVEGAN
Filing DateWednesday, December 6, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesVegan pharmaceutical preparations for the treatment of Histamine Intolerance containing diamine oxidase enzymes; Vegan chemico-pharmaceutical pharmaceutical preparations for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; Vegan sanitary preparations for medical purposes featuring diamine oxidase enzymes; Vegan biological preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; Vegan chemical preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; Vegan diamine oxidase enzymes and diamine oxidase enzyme preparations for medical purposes; dietetic foods adapted for medical purposes containing diamine oxidase enzymes; diagnostic preparations for medical purposes containing diamine oxidase enzymes; Vegan chemical reagents for medical purposes containing diamine oxidase enzymes; Vegan nutritional additives for medical purposes for use in foods and dietary supplements for human consumption, containing diamine oxidase enzymes; Vegan nutritional additives to foodstuffs for animals for medical purposes containing diamine oxidase enzymes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTADA Arzneimittel AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBad Vilbel 61118
DE

Trademark Events

Event DateEvent Description
Monday, March 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 6, 2023NEW APPLICATION ENTERED
Tuesday, June 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 25, 2024NON-FINAL ACTION WRITTEN
Tuesday, June 25, 2024NON-FINAL ACTION E-MAILED
Tuesday, June 25, 2024ASSIGNED TO EXAMINER
Thursday, September 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

daovegan diamine oxidase enzymes vegan purposes medical containing preparations intolerance treatment